Related Experiment Video
Updated: Apr 6, 2026

06:58
Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
Published on: January 24, 2020
7.9K
Sexual disinhibition and dementia
Gabriele Cipriani1, Martina Ulivi1, Sabrina Danti1
1Neurology Unit, Versilia Hospital, Lido di Camaiore, Italy.
Summary
Inappropriate sexual behavior (ISB) in dementia patients can stem from cognitive decline impacting intimacy needs. These behaviors, often intimacy-seeking or disinhibited, are best managed non-pharmacologically.
Area of Science:
- Neuroscience
- Gerontology
- Psychiatry
Background:
- Sexuality is a fundamental human need for intimacy.
- Cognitive decline in dementia can impair an individual's ability to express intimacy appropriately.
- Inappropriate sexual behavior (ISB) in dementia is a complex phenomenon influenced by biological, psychological, and environmental factors.
Purpose of the Study:
- To systematically describe the nature and characteristics of inappropriate sexual behavior (ISB) observed in patients with dementia.
- To explore the potential causes and contributing factors of ISB in the context of cognitive impairment.
- To differentiate types of ISB and their associations with dementia characteristics.
Main Methods:
- Comprehensive literature search of Cochrane Library, PubMed, and Web of Science from 1950 to 2014.
- Inclusion of relevant articles, chapters, and books using keywords: 'hypersexuality', 'inappropriate sexual behaviors', and 'dementia'.
- Review of identified publications for further relevant references.
Main Results:
- ISB in dementia can manifest as intimacy-seeking or disinhibited behaviors.
- These behaviors are associated with dementia type, severity, and potentially other concurrent disorders.
- While indifference is a common change, ISB can occur across dementia stages, notably in Alzheimer's and frontotemporal dementia.
Conclusions:
- ISB in dementia is a multifaceted issue requiring careful consideration of cognitive and behavioral changes.
- Non-pharmacological interventions are generally preferred for managing ISB due to potential limited response to psychoactive therapies.
- Effective management of ISB may not always be achieved solely through non-pharmacological approaches.
Related Concept Videos
Dementia
719
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
719
Dissociative Identity Disorder
1.9K
Dissociative Identity Disorder (DID), previously termed multiple personality disorder, is a complex psychological condition characterized by the presence of two or more distinct identities or personality states. Each identity exhibits unique patterns of behavior, voice, and mannerisms and may possess separate memories and emotional responses. The alternating control between identities can result in memory gaps and challenges in recalling daily activities, often exacerbating the individual's...
1.9K
Alzheimer's Disease: Overview
2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Sex Linked Disorders
29.4K
29.4K
Alzheimer's Disease: Treatment
1.2K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K
Dissociative Disorders
934
Dissociative disorders represent complex psychological conditions characterized by disruptions in consciousness, memory, identity, or perception. These disruptions cause individuals to experience a disconnection from their thoughts, emotions, and memories. The phenomenon is not merely an occasional lapse in attention but a profound alteration in mental functioning that can severely impact daily life.
Dissociative Fugue
A hallmark feature of dissociative disorders is the dissociative fugue...
Dissociative Fugue
A hallmark feature of dissociative disorders is the dissociative fugue...
934

